Cancer Drug Resistance

404 papers and 4.5k indexed citations i.

About

The 404 papers published in Cancer Drug Resistance in the last decades have received a total of 4.5k indexed citations. Papers published in Cancer Drug Resistance usually cover Molecular Biology (229 papers), Oncology (188 papers) and Cancer Research (123 papers) specifically the topics of Cancer Immunotherapy and Biomarkers (42 papers), MicroRNA in disease regulation (40 papers) and Cancer Cells and Metastasis (39 papers). The most active scholars publishing in Cancer Drug Resistance are Robert C.A.M. van Waardenburg, Bernhard Biersack, William H. Gmeiner, Prem Prakash Kushwaha and Godefridus J. Peters.

In The Last Decade

Fields of papers published in Cancer Drug Resistance

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Cancer Drug Resistance. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Cancer Drug Resistance

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Cancer Drug Resistance. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Cancer Drug Resistance with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025